Recent Updates
Recently added Catalysts
NTLA Positive Sentiment

Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2023 Earnings and Company Updates

Thursday, April 27, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Intellia Therapeutics, a prominent player in genome editing, has announced a conference call scheduled for May 4, 2023, to discuss its financial results for the first quarter of 2023 and provide operational updates. The call is intended for investors and stakeholders to gain insight into the company's performance and future direction. Callers can access the event through dedicated phone numbers and a live webcast, with a replay available afterward on Intellia's website.
Price reaction · baseline $36.23 (2023-04-26 close) · hit after-hours · 1 other NTLA headline(s) in the window, move may be shared
day 0 close
+0.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Intellia Therapeutics is a leading clinical-stage genome editing company.
  • The company is focused on potentially curative therapeutics.
  • Upcoming conference call will share significant updates and financial results.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+76%
120-day peak, hindsight
Typical move
9.6%
average across 8 past catalysts
Cash runway
~22 mo
Low dilution risk
Lead asset
NTLA-2002
Phase 3 · Hereditary Angioedema

Full Press Release Details

CAMBRIDGE, Mass., April 27, 2023 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing potentially curative therapeutics leveraging CRISPR-based technologies, will present its first quarter 2023 financial results and operational highlights in a conference call on May 4, 2023, at 8 a.m. ET.
U.S. callers should dial 1-833-316-0545 and international callers should dial 1-412-317-5726, approximately five minutes before the call. All participants should ask to be connected to the Intellia Therapeutics conference call.
Please visit this link for a simultaneous live webcast of the call.
A replay of the call will be available through the Events and Presentations page of the Investors & Media section on Intellia’s website at www.intelliatx.com, beginning on May 4, 2023, at 12 p.m. ET.
About Intellia Therapeutics

Frequently Asked Questions

When will Intellia Therapeutics present its Q1 2023 results?

Intellia Therapeutics will present its Q1 2023 results on May 4, 2023, at 8 a.m. ET.

How can I join the Intellia conference call?

U.S. callers should dial 1-833-316-0545; international callers should dial 1-412-317-5726.

Where can I watch the live webcast of the call?

You can access the live webcast through Intellia Therapeutics' official website.

When will the call replay be available?

The call replay will be accessible on May 4, 2023, at 12 p.m. ET.

Who can I contact for more information?

You can contact Ian Karp or Lina Li for investor relations inquiries.

ShareAdd on Google
Tags: NTLA Viatris Investor Conferences Healthcare Intellia Therapeutics genome editing CRISPR technologies Q1 earnings
Last updated: Apr 27, 2023

Biotech snapshot

Cash runway
$628M liquidity · $28M/mo burn
~22 mo
Low dilution risk
Lead asset
NTLA-2002Phase 3
Hereditary Angioedema →

Catalyst track record

+76%
best trade around NTLA's most recent catalyst

Peak hindsight return over a 120-day window, across 8 tracked FDA/PDUFA catalysts for NTLA.

See every catalyst's timing & PoA →